Dendritic cell ICAM-1 strengthens synapses with CD8 T cells but is not required for their early differentiation.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
29 08 2023
Historique:
received: 11 11 2021
revised: 13 06 2023
accepted: 10 07 2023
medline: 4 9 2023
pubmed: 26 7 2023
entrez: 26 7 2023
Statut: ppublish

Résumé

Lymphocyte priming in lymph nodes (LNs) was postulated to depend on the formation of stable T cell receptor (TCR)-specific immune synapses (ISs) with antigen (Ag)-presenting dendritic cells (DCs). The high-affinity LFA-1 ligand ICAM-1 was implicated in different ISs studied in vitro. We dissect the in vivo roles of endogenous DC ICAM-1 in Ag-stimulated T cell proliferation and differentiation and find that under type 1 polarizing conditions in vaccinated or vaccinia virus-infected skin-draining LNs, Ag-presenting DCs engage in ICAM-1-dependent stable conjugates with a subset of Ag-specific CD8 blasts. Nevertheless, in the absence of these conjugates, CD8 lymphocyte proliferation and differentiation into functional cytotoxic T cells (CTLs) and skin homing effector lymphocytes takes place normally. Our results suggest that although CD8 T cell blasts engage in tight ICAM-1-dependent DC-T ISs, firm ISs are dispensable for TCR-triggered proliferation and differentiation into productive effector lymphocytes.

Identifiants

pubmed: 37494182
pii: S2211-1247(23)00875-6
doi: 10.1016/j.celrep.2023.112864
pii:
doi:

Substances chimiques

Intercellular Adhesion Molecule-1 126547-89-5
Antigens 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112864

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Anita Sapoznikov (A)

Deptartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Stav Kozlovski (S)

Deptartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Nehora Levi (N)

Deptartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Sara W Feigelson (SW)

Deptartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Ofer Regev (O)

Deptartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Natalia Davidzohn (N)

Deptartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Shifra Ben-Dor (S)

Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.

Rebecca Haffner-Krausz (R)

Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.

Ester Feldmesser (E)

Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.

Noa Wigoda (N)

Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.

Ekaterina Petrovich-Kopitman (E)

Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.

Moshe Biton (M)

Deptartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel. Electronic address: moshe.biton@weizmann.ac.il.

Ronen Alon (R)

Deptartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel. Electronic address: ronen.alon@weizmann.ac.il.

Articles similaires

T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans
Killer Cells, Natural Animals Colorectal Neoplasms Decorin Adenoviridae
Humans Receptors, Antigen, T-Cell Proto-Oncogene Proteins p21(ras) Pancreatic Neoplasms T-Lymphocytes
Animals Humans Nickel Mice Immunotherapy

Classifications MeSH